These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 12898443

  • 1. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
    Hawes SE, Critchlow CW, Faye Niang MA, Diouf MB, Diop A, Touré P, Aziz Kasse A, Dembele B, Salif Sow P, Coll-Seck AM, Kuypers JM, Kiviat NB.
    J Infect Dis; 2003 Aug 15; 188(4):555-63. PubMed ID: 12898443
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM.
    J Infect Dis; 2001 Feb 01; 183(3):383-91. PubMed ID: 11133369
    [Abstract] [Full Text] [Related]

  • 4. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
    Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, Hall C, Bacon M, Levine AM, Watts DH, Silverberg MJ, Xue X, Schlecht NF, Melnick S, Palefsky JM.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):577-86. PubMed ID: 15840880
    [Abstract] [Full Text] [Related]

  • 5. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
    Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ.
    J Natl Cancer Inst; 2004 Jul 21; 96(14):1070-6. PubMed ID: 15265968
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection.
    Lillo FB, Lodini S, Ferrari D, Stayton C, Taccagni G, Galli L, Lazzarin A, Uberti-Foppa C.
    Clin Infect Dis; 2005 Feb 01; 40(3):451-7. PubMed ID: 15668870
    [Abstract] [Full Text] [Related]

  • 8. Effect of HIV infection on atypical squamous cells of undetermined significance.
    Duerr A, Paramsothy P, Jamieson DJ, Heilig CM, Klein RS, Cu-Uvin S, Schuman P, Anderson JR, HIV Epidemiology Research Study.
    Clin Infect Dis; 2006 Mar 15; 42(6):855-61. PubMed ID: 16477565
    [Abstract] [Full Text] [Related]

  • 9. Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 (HIV-1) RNA plasma level among women with HIV-1 infection.
    Luque AE, Demeter LM, Reichman RC.
    J Infect Dis; 1999 Jun 15; 179(6):1405-9. PubMed ID: 10228061
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women.
    Denny L, Boa R, Williamson AL, Allan B, Hardie D, Stan R, Myer L.
    Obstet Gynecol; 2008 Jun 15; 111(6):1380-7. PubMed ID: 18515522
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women.
    Rowhani-Rahbar A, Hawes SE, Sow PS, Toure P, Feng Q, Dem A, Dembele B, Critchlow CW, N'Doye I, Kiviat NB.
    J Infect Dis; 2007 Sep 15; 196(6):887-94. PubMed ID: 17703420
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.
    Hankins C, Coutlée F, Lapointe N, Simard P, Tran T, Samson J, Hum L.
    CMAJ; 1999 Jan 26; 160(2):185-91. PubMed ID: 9951439
    [Abstract] [Full Text] [Related]

  • 14. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
    Viscidi RP, Ahdieh-Grant L, Clayman B, Fox K, Massad LS, Cu-Uvin S, Shah KV, Anastos KM, Squires KE, Duerr A, Jamieson DJ, Burk RD, Klein RS, Minkoff H, Palefsky J, Strickler H, Schuman P, Piessens E, Miotti P.
    J Infect Dis; 2003 Jan 15; 187(2):194-205. PubMed ID: 12552444
    [Abstract] [Full Text] [Related]

  • 15. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
    Richter KL, van Rensburg EJ, van Heerden WF, Boy SC.
    J Oral Pathol Med; 2008 Oct 15; 37(9):555-9. PubMed ID: 18355174
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Human papillomavirus type in anal epithelial lesions is influenced by human immunodeficiency virus.
    Unger ER, Vernon SD, Lee DR, Miller DL, Sharma S, Clancy KA, Hart CE, Reeves WC.
    Arch Pathol Lab Med; 1997 Aug 15; 121(8):820-4. PubMed ID: 9278609
    [Abstract] [Full Text] [Related]

  • 19. Effect of anal epidermoid cancer-related viruses on the dendritic (Langerhans') cells of the human anal mucosa.
    Sobhani I, Walker F, Aparicio T, Abramowitz L, Henin D, Cremieux AC, Soule JC.
    Clin Cancer Res; 2002 Sep 15; 8(9):2862-9. PubMed ID: 12231528
    [Abstract] [Full Text] [Related]

  • 20. Human papillomavirus infection among HIV-infected individuals. Implications for development of malignant tumors.
    Palefsky J.
    Hematol Oncol Clin North Am; 1991 Apr 15; 5(2):357-70. PubMed ID: 1850727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.